Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Lumigan (bimatoprost ophthalmic solution), 0.03%, Allergan, NDA 21-275/S10 & S12 8/25/03 8/28/03 8/28/03 | Lumigan (bimatoprost ophthalmic solution), 0.03%, Allergan, NDA 21-275/S6 8/26/02 8/30/02 8/26/02 | Lumigan (bimatoprost ophthalmic solution), 0.03%, Allergan, NDA 21-275 3/16/01 4/19/01 8/20/01 | Lumigan Indications: for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive [failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication. Lumigan (bimatoprost ophthalmic solution), Allergan | Lumigan (Bimatoprost) Ophthalmic Solution, Allergan, Inc., New or Modified Indication | Latisse (bimatoprost) Ophthalmic Solution, Allergan, Inc., Approval | Lumigan (bimatoprost) Ophthalmic Solution, Allergan, Inc., Approval | Bimatoprost Ophthalmic Solution, Apotex Inc., Tentative Approval | Bimatoprost Ophthalmic Solution, Sandoz Inc., Tentative Approval | Latisse (bimatoprost) Ophthalmic Solution, Allergan, Inc., Labeling Revision | Latisse (bimatoprost) Ophthalmic Solution, Allergan, Inc., Manufacturing Supplement ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com